Generation of composites for bone tissue-engineering applications consisting of gellan gum hydrogels mineralized with calcium and magnesium phosphate phases by enzymatic means

Journal of Tissue Engineering and Regenerative Medicine

Volumn 10, Issue 11, 2016, Pages 938-954

  Douglas, Timothy E L ^a   Krawczyk, Grzegorz ^b   Pamula, Elzbieta ^b   Declercq, Heidi A ^a   Schaubroeck, David ^c   Bucko, Miroslaw M ^b   Balcaen, Lieve ^a   Van Der Voort, Pascal ^a   Bliznuk, Vitaliy ^d   van den Vreken, Natasja M F ^a   Dash, Mamoni ^a   Detsch, Rainer ^e   Boccaccini, Aldo R ^e   Vanhaecke, Frank ^a   Cornelissen, Maria ^a   Dubruel, Peter ^a  

^a GHENT UNIVERSITY   (Belgium)

^b AGH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Poland)

^c IMEC   (Belgium)

^d Technologiepark Zwijnaarde   (Belgium)

^e UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

calcium phosphate; composite; cytocompatibility; enzyme; gellan gum; hydrogel; magnesium phosphate; osteoblast

Indexed keywords

BONE; CALCIUM PHOSPHATE; COPYRIGHTS; ELASTIC MODULI; HYDROXYAPATITE; MAGNESIUM COMPOUNDS; MINERALOGY; PHOSPHATASES; PHOSPHOLIPIDS; TISSUE ENGINEERING;

ALKALINE PHOSPHATASE; AMORPHOUS PHASIS; BONE REGENERATION; BONE TISSUE ENGINEERING; CALCIUM AND MAGNESIUM PHOSPHATES; CALCIUM DEFICIENT HYDROXYAPATITE; CYTOCOMPATIBILITY; GELLAN GUM; MINERALISATION; TISSUE ENGINEERING APPLICATIONS;

HYDROGELS;

CALCIUM; CALCIUM DEFICIENT HYDROXYAPATITE; GELLAN; GLYCEROPHOSPHATE; GLYCEROPHOSPHATE CALCIUM; HYDROXYAPATITE; MAGNESIUM GLYCEROPHOSPHATE; UNCLASSIFIED DRUG; BACTERIAL POLYSACCHARIDE; CALCIUM PHOSPHATE; MAGNESIUM DERIVATIVE; MAGNESIUM PHOSPHATE; PHOSPHATE;

ARTICLE; BIODEGRADATION; CELL ADHESION; CONTROLLED STUDY; CULTURE MEDIUM; DRY MASS; ELECTRON DIFFRACTION; HUMAN; HUMAN CELL; HYDROGEL; ION COUPLED PLASMA OPTICAL EMISSION SPECTROSCOPY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MINERALIZATION; OSTEOBLAST; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SELECTED AREA ELECTRON DIFFRACTION; SPECTROSCOPY; THERMOGRAVIMETRY; TISSUE ENGINEERING; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION; YOUNG MODULUS; ANIMAL; BONE; BONE MINERALIZATION; CHEMISTRY; CYTOLOGY; FIBROBLAST; MALE; METABOLISM; MOUSE; RAW 264.7 CELL LINE;

ANIMALS; BONE AND BONES; CALCIFICATION, PHYSIOLOGIC; CALCIUM PHOSPHATES; FIBROBLASTS; HUMANS; HYDROGELS; MAGNESIUM COMPOUNDS; MALE; MICE; OSTEOBLASTS; PHOSPHATES; POLYSACCHARIDES, BACTERIAL; RAW 264.7 CELLS; TISSUE ENGINEERING;

EID: 84894242684     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.1875     Document Type: Article

References (71)

1. Abbona F, Lundager Masen HE, Boistelle R. 1986; The intital phases of calcium and magnesium phosphates precipitated from solutions of high to medium concentrations. J Cryst Growth 74: 581–590.
2. Aoba T, Moreno EC, Shimoda S. 1992; Competitive adsorption of magnesium and calcium ions onto synthetic and biological apatites. Calcif Tissue Int 51: 143–150.
3. Bachra BN, Trautz OR, Simon SL. 1965; Precipitation of calcium carbonates and phosphates. 3. The effect of magnesium and fluoride ions on the spontaneous precipitation of calcium carbonates and phosphates. Arch Oral Biol 10: 731–738.
4. Beertsen W, Van Den Bos T. 1992; Alkaline phosphatase induces the mineralization of sheets of collagen implanted subcutaneously in the rat. J Clin Invest 89: 1974–1980.
5. Blumenthal NC, Betts F, Posner AS. 1977; Stabilization of amorphous calcium phosphate by Mg and ATP. Calcif Tissue Res 23: 245–250.
6. Boanini E, Torricelli P, Fini M, et al. 2012; Magnesium and strontium doped octacalcium phosphate thin films by matrix assisted pulsed laser evaporation. J Inorg Biochem 107: 65–72.
7. Bongio M, Nejadnik MR, Birgani ZT, et al. 2013; In vitro and in vivo enzyme-mediated biomineralization of oligo[poly(ethylene glycol)] fumarate hydrogels. Macromol Biosci 13: 777–788.
8. Boskey AL, Posner AS. 1974; Magnesium stabilization of amorphous calcium phosphate: a kinetic study. Mater Res Bull 9: 907–916.
9. 2+ on the chemicophysical and in vitro biological properties of calcium phosphate biomimetic coatings. J Inorg Biochem 103: 1666–1674.
10. 2O. Am Mineralog 71: 1229–1233.
11. Cai YL, Zhang JJ, Zhang S, et al. 2010; Osteoblastic cell response on fluoridated hydroxyapatite coatings: the effect of magnesium incorporation. Biomed Mater 5: 054114.
12. Detsch R, Hagmeyer D, Neymann M, et al. 2010; The resorption of nanocrystalline calcium phosphates by osteoclast-like cells. Acta Biomater 6: 3223–3233.
13. Detsch R, Schaefer S, Deisinger U, et al. 2011; In vitro osteoclastic activity studies on surfaces of 3D printed calcium phosphate scaffolds. J Biomater Applic 26: 359–380.
14. Doi Y, Horiguchi T, Moriwaki Y, et al. 1996; Formation of apatite–collagen complexes. J Biomed Mater Res 31: 43–49.
15. Douglas T, Wlodarczyk M, Pamula E, et al. 2012a; Enzymatic mineralization of gellan gum hydrogel for bone tissue-engineering applications and its enhancement by polydopamine. J Tissue Eng Regen Med DOI: 10.1002/term.1616
16. Douglas TE, Gassling V, Declercq HA, et al. 2012b; Enzymatically induced mineralization of platelet-rich fibrin. J Biomed Mater Res A 100: 1335–1346.
17. Douglas TE, Messersmith PB, Chasan S, et al. 2012c; Enzymatic mineralization of hydrogels for bone tissue engineering by incorporation of alkaline phosphatase. Macromol Biosci 12: 1077–1089.
18. Draenert M, Draenert A, Draenert K. 2013; Osseointegration of hydroxyapatite and remodeling–resorption of tricalciumphosphate ceramics. Microsc Res Tech 76: 370–380.
19. Engler AJ, Sen S, Sweeney HL, et al. 2006; Matrix elasticity directs stem cell lineage specification. Cell 126: 677–689.
20. Evans ND, Minelli C, Gentleman E, et al. 2009; Substrate stiffness affects early differentiation events in embryonic stem cells. Eur Cell Mater 18: 1–13; discussion, 13–14.
21. Ewald A, Helmschrott K, Knebl G, et al. 2011; Effect of cold-setting calcium and magnesium phosphate matrices on protein expression in osteoblastic cells. J Biomed Mater Res B Appl Biomater 96: 326–332.
22. Fadilogwlu S, Erkmen O, Sekerogwlu G. 2004; Inactivation of alkaline phosphatase in milk. Food Technol Biotechnol 42: 27–32.
23. Fan J, Gong Y, Ren L, et al. 2010; In vitro engineered cartilage using synovium-derived mesenchymal stem cells with injectable gellan hydrogels. Acta Biomater 6: 1178–1185.
24. Fialho AM, Moreira LM, Granja AT, et al. 2008; Occurrence, production, and applications of gellan: current state and perspectives. Appl Microbiol Biotechnol 79: 889–900.
25. Filmon R, Basle MF, Barbier A, et al. 2000; Poly(2-hydroxy ethyl methacrylate)-alkaline phosphatase: a composite biomaterial allowing in vitro studies of bisphosphonates on the mineralization process. J Biomater Sci Polym Ed 11: 849–868.
26. Frost RL, Martens W, Williams PA, et al. 2002; Raman and infrared spectroscopic study of the vivianite-group phosphates vivianite, baricite, and bobierrite. Mineralog Mag 66: 1063–1073.
27. Giavasis I, Harvey LM, McNeil B. 2000; Gellan gum. Crit Rev Biotechnol 20: 177–211.
28. Gkioni K, Leeuwenburgh SC, Douglas TE, et al. 2010; Mineralization of hydrogels for bone regeneration. Tissue Eng B Rev 16: 577–585.
29. Gunther KP, Scharf HP, Pesch HJ, et al. 1998; [Integration properties of bone substitute materials. Experimental studies on animals]. Orthopade 27: 105–117.
30. Hwang JW, Park JS, Lee JS, et al. 2012; Comparative evaluation of three calcium phosphate synthetic block bone graft materials for bone regeneration in rabbit calvaria. J Biomed Mater Res B Appl Biomater 100: 2044–2052.
31. Janning C, Willbold E, Vogt C, et al. 2010; Magnesium hydroxide temporarily enhancing osteoblast activity and decreasing the osteoclast number in peri-implant bone remodelling. Acta Biomater 6: 1861–1868.
32. Juhasz JA, Best SM, Bonfield W. 2010; Preparation of novel bioactive nano-calcium phosphate–hydrogel composites. Sci Technol Adv Mater 11: 1–7.
33. Jung CR, Schepetkin IA, Woo SB, et al. 2002; Osteoblastic differentiation of mesenchymal stem cells by mumie extract. Drug Dev Res 57: 122–133.
34. Klammert U, Ignatius A, Wolfram U, et al. 2011; In vivo degradation of low temperature calcium and magnesium phosphate ceramics in a heterotopic model. Acta Biomater 7, 3469–3475.
35. Klammert U, Reuther T, Blank M, et al. 2010; Phase composition, mechanical performance and in vitro biocompatibility of hydraulic setting calcium magnesium phosphate cement. Acta Biomater 6: 1529–1535.
36. Koutsopoulos S. 2002; Synthesis and characterization of hydroxyapatite crystals: a review study on the analytical methods. J Biomed Mater Res 62: 600–612.
37. 3-substituted hydroxyapatites: synthesis, characterization and in vitro behaviour. J Eur Ceram Soc 26: 2593–2601.
38. 2+ differentially regulate β1-integrin-mediated adhesion of dermal fibroblasts and keratinocytes to various extracellular matrix proteins. Exp Cell Res 214: 381–388.
39. 2+) differentially influence the β1-integrin-mediated migration of human fibroblasts and keratinocytes to different extracellular matrix proteins. Exp Dermatol 4: 130–137.
40. Legeros RZ. 1991; Calcium Phosphates in Oral Biology and Medicine. Karger: Basel.
41. Lombardi P, Avallone L, D'Angelo A, et al. 2000; Buffalo-milk enzyme levels, their sensitivity to heat inactivation, and their possible use as markers for pasteurization. J Food Prot 63: 970–973.
42. Mahamid J, Sharir A, Addadi L, et al. 2008; Amorphous calcium phosphate is a major component of the forming fin bones of zebrafish: indications for an amorphous precursor phase. Proc Natl Acad Sci U S A 105: 12748–12753.
43. 4)2O at 37.4 °C. Calcif Tissue Int 60: 538–546.
44. 2O at 5, 15, 25 and 37 °C. J Res Natl Bur Stand A 81A: 273–281.
45. Mestres G, Ginebra MP. 2011; Novel magnesium phosphate cements with high early strength and antibacterial properties. Acta Biomater 7: 1853–1861.
46. Moore WR, Graves SE, Bain GI. 2001; Synthetic bone graft substitutes. ANZ J Surg 71: 354–361.
47. Moseke C, Saratsis V, Gbureck U. 2011; Injectability and mechanical properties of magnesium phosphate cements. J Mater Sci Mater Med 22: 2591–2598.
48. Neale FC, Clubb JS, Hotchkis D, et al. 1965; Heat stability of human placental alkaline phosphatase. J Clin Pathol 18: 359–363.
49. Neumann WF, Mulryan BJ. 1971; Synthetic hydroxyapatite crystals. IV. Magnesium incorporation. Calcif Tissue Res 7: 133–138.
50. Okamoto T, Kubota K. 1996; Sol–gel transition of polysaccharide gellan gum. Carbohydr Polym 30: 149–153.
51. Oliveira JT, Martins L, Picciochi R, et al. 2010; Gellan gum: a new biomaterial for cartilage tissue engineering applications. J Biomed Mater Res A 93: 852–863.
52. Rowlands AS, George PA, Cooper-White JJ. 2008; Directing osteogenic and myogenic differentiation of MSCs: interplay of stiffness and adhesive ligand presentation. Am J Physiol Cell Physiol 295: C1037–1044.
53. Roy M, Bose S. 2012; Osteoclastogenesis and osteoclastic resorption of tricalcium phosphate: effect of strontium and magnesium doping. J Biomed Mater Res A 100A: 2450–2461.
54. Ruhe PQ, Boerman OC, Russel FG, et al. 2005; Controlled release of rhBMP-2 loaded poly(dl-lactic-co-glycolic acid)/calcium phosphate cement composites in vivo. J Control Release 106: 162–171.
55. Ryu J, Ku SH, Lee H, et al. 2010; Mussel-inspired polydopamine coating as a universal route to hydroxyapatite crystallization. Adv Funct Mater 20: 2132–2139.
56. Sader MS, Legeros RZ, Soares GA. 2009; Human osteoblasts adhesion and proliferation on magnesium-substituted tricalcium phosphate dense tablets. J Mater Sci Mater Med 20: 521–527.
57. Schaefer S, Detsch R, Uhl F, et al. 2011; How degradation of calcium phosphate bone substitute materials is influenced by phase composition and porosity. Adv Eng Mater 13: 342–350.
58. Schouten C, Van Den Beucken JJ, De Jonge LT, et al. 2009; The effect of alkaline phosphatase coated onto titanium alloys on bone responses in rats. Biomaterials 30: 6407–6417.
59. Spoerke ED, Anthony SG, Stupp SI. 2009; Enzyme directed templating of artificial bone mineral. Adv Mater 21: 425–430.
60. Tamimi F, Le Nihouannen D, Bassett DC, et al. 2012; Biocompatibility of magnesium phosphate minerals and their stability under physiological conditions. Acta Biomater 7: 2678–2685.
61. Tay KC, Loushine BA, Oxford C, et al. 2007; In vitro evaluation of a Ceramicrete-based root-end filling material. J Endod 33: 1438–1443.
62. Taylor AW, Frazier AW, Gurney EL, et al. 1963; Solubility products of di- and trimagnesium phosphates and the dissociation of magnesium phosphate solutions. Trans Faraday Soc 59: 1585–1589.
63. Van Den Vreken NM, Pieters IY, De Maeyer EA, et al. 2006; Apatite formation in composites of α-TCP and degradable polyesters. J Biomater Sci Polym Ed 17: 953–967.
64. Webster TJ, Ergun C, Doremus RH, et al. 2002; Hydroxylapatite with substituted magnesium, zinc, cadmium, and yttrium. II. Mechanisms of osteoblast adhesion. J Biomed Mater Res 59: 312–317.
65. Wei S, Teitelbaum SL, Wang MWH, et al. 2001; Receptor activator of nuclear factor-κB ligand activates nuclear factor-κB in osteoclast precursors. Endocrinology 142: 1290–1295.
66. Xue W, Dahlquist K, Banerjee A, et al. 2008; Synthesis and characterization of tricalcium phosphate with Zn and Mg based dopants. J Mater Sci Mater Med 19: 2669–2677.
67. 3Ap–collagen composite in promoting bone formation. Biomaterials 24: 4913–4920.
68. 3 apatite accelerating osteoblast adhesion. J Biomed Mater Res 62: 99–105.
69. Yamauchi K, Goda T, Takeuchi N, et al. 2004; Preparation of collagen/calcium phosphate multilayer sheet using enzymatic mineralization. Biomaterials 25: 5481–5489.
70. Zhao SF, Jiang QH, Peel S, et al. 2013; Effects of magnesium-substituted nanohydroxyapatite coating on implant osseointegration. Clin Oral Implants Res 24(Suppl A100): 34–41.
71. Zreiqat H, Howlett CR, Zannettino A, et al. 2002; Mechanisms of magnesium-stimulated adhesion of osteoblastic cells to commonly used orthopaedic implants. J Biomed Mater Res 62: 175–184.